@article{137852d4b4854502b3ee345a2cf9c53b,
title = "What Are We Waiting for? - Start Screening High-risk Individuals for Anal Cancer Now",
author = "Terlizzi, \{Joseph P.\} and Jonathan Baker and Goldstone, \{Stephen E.\}",
note = "Funding Information: Published Online: September 29, 2021. doi:10.1001/jamadermatol.2021.3832 Conflict of Interest Disclosures: Dr Goldstone reported grants and personal fees from Merck, Inovio, Medtronic, and THD America. Dr Terlizzi and Mr Baker participate in studies funded by Inovio, Antiva, Merck, and Medtronic outside the submitted work. No other disclosures were reported. 1. Arnold JD, Byrne ME, Monroe AK, Abbott SE; District of Columbia Cohort Executive Committee. The risk of anal carcinoma after anogenital warts in adults living with HIV. JAMA Dermatol. 2021;157(3):283-289. doi:10.1001/ jamadermatol.2020.5252 2. Goldstone SE, Johnstone AA, Moshier EL. Long-term outcome of ablation of anal high-grade squamous intraepithelial lesions: recurrence and incidence of cancer. Dis Colon Rectum. 2014;57(3):316-323. doi:10.1097/DCR. 0000000000000058 3. Gaisa MM, Liu Y, Deshmukh AA, Stone KL, Sigel KM. Electrocautery ablation of anal high-grade squamous intraepithelial lesions: effectiveness and key factors associated with outcomes. Cancer. 2020;126(7):1470-1479. doi:10. 1002/cncr.32581 4. Cajas-Monson LC, Ramamoorthy SL, Cosman BC. Expectant management of high-grade anal dysplasia in people with HIV: long-term data. Dis Colon Rectum. 2018;61(12):1357-1363. doi:10.1097/DCR.0000000000001180 5. Sambursky JA, Terlizzi JP, Goldstone SE. Testing for human papillomavirus strains 16 and 18 helps predict the presence of anal high-grade squamous intraepithelial lesions. Dis Colon Rectum. 2018;61(12):1364-1371. doi:10.1097/ DCR.0000000000001143",
year = "2021",
month = nov,
doi = "10.1001/jamadermatol.2021.3832",
language = "English",
volume = "157",
pages = "1383--1384",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "11",
}